(Q43960826)

English

Organ preservation in patients with invasive bladder cancer: initial results of an intensified protocol of transurethral surgery and radiation therapy plus concurrent cisplatin and 5-fluorouracil

scientific article published in April 2002

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Organ preservation in patients with invasive bladder cancer: initial results of an intensified protocol of transurethral surgery and radiation therapy plus concurrent cisplatin and 5-fluorouracil (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

adaptive radiation therapy

0 references

1 reference

based on heuristic

inferred from title

1

object named as

Claus Rödel

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

author name string

Gerhard G Grabenbauer

2

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Reinhard Kühn

3

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Thomas Zörcher

4

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Thomas Papadopoulos

5

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Jürgen Dunst

6

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Karl M Schrott

7

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Rolf Sauer

8

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

language of work or name

0 references

publication date

1 April 2002

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

International Journal of Radiation Oncology Biology Physics

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

52

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

1303-1309

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902771-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902771-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group phase II trial 8802

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902771-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Bladder preservation by combined modality therapy for invasive bladder cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902771-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Invasive bladder cancer: our experience with bladder sparing approach

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902771-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of radiochemotherapy with platin derivatives compared to radiotherapy alone in organ-sparing treatment of bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902771-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiotherapy is an effective treatment for high-risk T1-bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902771-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Bladder preservation in muscle-invasive bladder cancer by conservative surgery and radiochemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902771-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902771-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902771-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Concomitant radiochemotherapy with 5-FU and cisplatin for invasive bladder cancer. Acute toxicity and first results

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902771-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902771-7

7 January 2021

based on heuristic

inferred from DOI database lookup

RTOG Late Effects Working Group. Overview. Late Effects of Normal Tissues (LENT) scoring system

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902771-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Organ-sparing treatment of advanced bladder cancer: a 10-year experience

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902771-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiotherapy alone or radiochemotherapy with platin derivatives following transurethral resection of the bladder. Organ preservation and survival after treatment of bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902771-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase I/II trial of transurethral surgery combined with concurrent cisplatin, 5-fluorouracil and twice daily radiation followed by selective bladder preservation in operable patients with muscle invading bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902771-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The initial results in muscle-invading bladder cancer of RTOG 95-06: phase I/II trial of transurethral surgery plus radiation therapy with concurrent cisplatin and 5-fluorouracil followed by selective bladder preservation or cystectomy depending on

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902771-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Preliminary results of simultaneous radiochemotherapy with paclitaxel for urinary bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902771-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0360-3016(01)02771-7

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43960826&oldid=2105035599"